For example, a cancer such as metastatic melanoma, which has high TMB, but is non-T-cell-inflamed (genomically high levels of mutations but phenotypically an immunologically cold tumor), can be rendered responsive to ICIs by treatment with a combination of oncolytic virus therapy and anti-PD-1 therapy [23]. Here, PDCD1 is linked to neoplasm.